| Cash Flow | 2025-07-31 |
|---|---|
| Net loss | -2,399 |
| Share-based compensation | 147 |
| Depreciation and amortization | 2 |
| Accounts receivable | 176 |
| Inventories | 85 |
| Prepaid expenses | -4 |
| Accounts payable and accrued liabilities | 205 |
| Interest on note payable | 287 |
| Net cash used in operating activities | -2,015 |
| Net proceeds from convertible notes payable to related parties | 2,000 |
| Net cash provided by financing activities | 2,000 |
| Net decrease in cash, cash equivalents, and restricted cash | -15 |
| Cash and cash equivalents at beginning of period | 424 |
| Cash and cash equivalents at end of period | 409 |
PURE BIOSCIENCE, INC. (PURE)
PURE BIOSCIENCE, INC. (PURE)